followers 0 popularity
following 1

following  view all

mrfrreports is not in any groups

Immortalized Cell Line Market Analytical Overview, Comprehensive Analysis And Trends

Mar 26th 2020 at 1:27 AM

Immortalized Cell Line Market Overview

Immortalized cell lines have wide application in the field of healthcare and life science. Increasing adoption of cell line system in cancer therapy, increasing research and development activities and growth in biotechnology sector drive the global immortalized cell line market. The global immortalized cell line market is expected to grow at a CAGR of 9.30% is anticipated to reach USD 4,105.62 million during 2017-2023.

Demand for organ transplant has been on the rise but there is a scarcity in the availability of organs. For instance, according to the American Transplant Foundation, as of 2019, nearly 114,000 people are waiting on the organ transplant list in the U.S. alone and nearly 20 people die every day due to the lack of viable organs. Researchers have therefore been working to develop artificial biological cells which would in turn drive the immortalized cell line market.

Moreover, the rising incidence of cancer and urgent need to find effective treatment for the various types of cancer, are factors that will potentially boost the immortalized cell line market. Researchers and scientists often study the cells from an extracted tumor to understand what are the conditions that are triggering the growth of cancerous cells and develop means through which it can be ascertained how much cancer is in the body and predict how the cancer will behave and in what way it will respond to treatment.

The high cost of equipment and difficulty in stable cell line development can prove to be some of the obstacles in the growth path of immortalized cell line market but increased financial support provided by government and private entities would be suffice to overcome such hurdles and lead to future industry growth.

Immortalized Cell Line Market Segmentation:

Immortalized cell line market research has been segmented according to method, application, and end user.

According to method, immortalized cell line market is classified into virus hTERT expression, induction, inactivation of tumor suppression genes, and others.

By application, immortalized cell line market, is divided into drug discovery, diagnostics, tissue engineering and regenerative medicine, vaccine production, and others.

End user segmentation of immortalized cell line market includes Contract Research Organizations (CROs), pharmaceutical and biopharmaceutical companies, and research laboratories. The pharmaceutical and biopharmaceutical companies segment amassed a revenue of approximately USD 1,323.79 million in 2017.

Immortalized Cell Line Market Regional Analysis:

Regional segmentation of immortalized cell line market has been done on the basis of Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold a dominating position in the global immortalized cell line market owing to the presence of well-established pharmaceutical and biotechnology industry in the region as well as greater incidence of cancer, expansive research funding and increasing awareness about immortalized cell lines.

Europe immortalized cell line market size is anticipated to be second to that of the Americas during the forecast period. Robust government support, technology advancements in healthcare, and rising incidence of cancer would boost market growth in the region.

Asia-Pacific immortalized cell line market is anticipated to record fastest-growth due to the increasing expenditure by governments on enhancement of healthcare facilities. Expanding research for betterment of healthcare offerings and expansive patient population have attracted key players to shift their focus to the region which has helped Asia Pacific to register a market share of 17.8% in 2017.

Immortalized Cell Line Market Competitive Overview:

Some of the prominent players in the immortalized cell line market include Thermo Fisher Scientific, American Type Culture Collection Inc., Valneva, Sartorius AG, Lonza Group, AG, Merck KGaA (Germany), Selexis SA, WuXi App Tec, European Collection of Authenticated Cell Cultures, and Corning Incorporated.

Immortalized Cell Line Industry News:

Immortalized cell line market will witness expansion owing to the varied application of the process in development of novel therapeutics for diseases ranging from cancer to malaria. For instance, researchers at the Imperial College London and University of Bristol have established a system that utilizes lab grown red blood cells to study the mechanism that is adopted by malaria parasites to invade red blood cells.

The work, which is aimed at facilitating understanding and disruption of the mechanism of red blood cell invasion by malaria parasites, is funded by NHS Blood and Transplant and the National Institute for Health Research.

Browse Complete Report with TOC at

Plasmodium falciparum is the malaria parasite that infects nearly 200 million people and causes half a million deaths each year around the world. For the experiment, researchers have used immortalized cell line technology to produce unlimited numbers of immature 'progenitor cells' that can be manipulated to produce new red blood cells (reticulocytes) in the lab. The researchers were able to show that cells produced in the technique could support both invasion by and intracellular development of Plasmodium falciparum.

Please to comment

sign in

Remember Me

New to IM faceplate? join free!

Lost Password? click here